Pubblicazioni

Autori:

Danese, Elisabetta; Curic, Tea; Bellinato, Francesco; Colato, Chiara; Gisondi, Paolo; Girolomoni, Giampiero

Titolo:

Upadacitinib in refractory cutaneous pseudolymphoma: A case report

Anno:

2025

Tipologia prodotto:

Articolo in Rivista

Tipologia ANVUR:

Articolo su rivista

Lingua:

Inglese

Referee:

No

Nome rivista:

SAGE OPEN MEDICAL CASE REPORTS

ISSN Rivista:

2050-313X

Intervallo pagine:

1-4

Parole chiave:

upadacitinib, cutaneous pseudolymphoma, JAK inhibitors

Breve descrizione dei contenuti:

Cutaneous pseudolymphoma is a benign condition characterized by a reactive B-cell, T-cell or mixed lymphoproliferative process. Different causative agents (e.g. injected substances, tattoo, drugs and insect bites) have been described, but in many cases no cause can be identified; hence, the term idiopathic cutaneous pseudolymphoma. There are no specific guidelines for the treatment of cutaneous pseudolymphoma, and sometimes a few cases are refractory to conventional treatments. We describe a case of a 41-year-old African woman with refractory facial IgG4 pseudolymphoma successfully treated with upadacitinib.

Id prodotto:

146520

Handle IRIS:

11562/1165707

ultima modifica:

27 giugno 2025

Citazione bibliografica:

Danese, Elisabetta; Curic, Tea; Bellinato, Francesco; Colato, Chiara; Gisondi, Paolo; Girolomoni, Giampiero, Upadacitinib in refractory cutaneous pseudolymphoma: A case report «SAGE OPEN MEDICAL CASE REPORTS» , 2025 , pp. 1-4

Consulta la scheda completa presente nel repository istituzionale della Ricerca di Ateneo